These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32505357)

  • 1. DUSP4 is involved in the enhanced proliferation and survival of DUSP4-overexpressing cancer cells.
    Ratsada P; Hijiya N; Hidano S; Tsukamoto Y; Nakada C; Uchida T; Kobayashi T; Moriyama M
    Biochem Biophys Res Commun; 2020 Jul; 528(3):586-593. PubMed ID: 32505357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of dual-specificity phosphatase 4 enhances cell proliferation and invasiveness in colorectal carcinomas.
    Ichimanda M; Hijiya N; Tsukamoto Y; Uchida T; Nakada C; Akagi T; Etoh T; Iha H; Inomata M; Takekawa M; Moriyama M
    Cancer Sci; 2018 Jan; 109(1):250-258. PubMed ID: 29150975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.
    Mazumdar A; Poage GM; Shepherd J; Tsimelzon A; Hartman ZC; Den Hollander P; Hill J; Zhang Y; Chang J; Hilsenbeck SG; Fuqua S; Kent Osborne C; Mills GB; Brown PH
    Breast Cancer Res Treat; 2016 Aug; 158(3):441-54. PubMed ID: 27393618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation.
    Gröschl B; Bettstetter M; Giedl C; Woenckhaus M; Edmonston T; Hofstädter F; Dietmaier W
    Int J Cancer; 2013 Apr; 132(7):1537-46. PubMed ID: 22965873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Dusp4 and p53 loss with Dbf4 amplification drives tumorigenesis via cell cycle restriction and replication stress escape in breast cancer.
    Hanna A; Nixon MJ; Estrada MV; Sanchez V; Sheng Q; Opalenik SR; Toren AL; Bauer J; Owens P; Mason FM; Cook RS; Sanders ME; Arteaga CL; Balko JM
    Breast Cancer Res; 2022 Jul; 24(1):51. PubMed ID: 35850776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual specificity phosphatase (DUSP)-4 is induced by platelet-derived growth factor -BB in an Erk1/2-, STAT3- and p53-dependent manner.
    Yin R; Eger G; Sarri N; Rorsman C; Heldin CH; Lennartsson J
    Biochem Biophys Res Commun; 2019 Nov; 519(3):469-474. PubMed ID: 31526568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-Specificity Phosphatase 4 Promotes Malignant Features in Colorectal Cancer Through Cyclic-AMP Response Element Binding Protein/Protein Kinase CAMP-Activated Catalytic Subunit Beta Activation.
    Pei W; Yin W; Yu T; Zhang X; Zhang Q; Yang X; Shi C; Shen W; Liu G
    Dig Dis Sci; 2024 Aug; 69(8):2856-2874. PubMed ID: 38824257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency.
    Jung HH; Lee SH; Kim JY; Ahn JS; Park YH; Im YH
    Sci Rep; 2016 Sep; 6():33035. PubMed ID: 27604655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sanguinarine inhibits growth and invasion of gastric cancer cells via regulation of the DUSP4/ERK pathway.
    Zhang R; Wang G; Zhang PF; Zhang J; Huang YX; Lu YM; Da W; Sun Q; Zhu JS
    J Cell Mol Med; 2017 Jun; 21(6):1117-1127. PubMed ID: 27957827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance.
    Balko JM; Cook RS; Vaught DB; Kuba MG; Miller TW; Bhola NE; Sanders ME; Granja-Ingram NM; Smith JJ; Meszoely IM; Salter J; Dowsett M; Stemke-Hale K; González-Angulo AM; Mills GB; Pinto JA; Gómez HL; Arteaga CL
    Nat Med; 2012 Jul; 18(7):1052-9. PubMed ID: 22683778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox activation of DUSP4 by N-acetylcysteine protects endothelial cells from Cd²⁺-induced apoptosis.
    Barajas-Espinosa A; Basye A; Jesse E; Yan H; Quan D; Chen CA
    Free Radic Biol Med; 2014 Sep; 74():188-199. PubMed ID: 24973647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR‑122‑5p suppresses the oncogenesis of PTC by inhibiting DUSP4 expression.
    Hu N; Tian Y; Song Y; Zang L
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARID1A loss activates MAPK signaling via DUSP4 downregulation.
    Mandal J; Yu ZC; Shih IM; Wang TL
    J Biomed Sci; 2023 Dec; 30(1):94. PubMed ID: 38071325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of human DUSP4 gene by cancer-related transcription factors.
    Varela T; Conceição N; Laizé V; Cancela ML
    J Cell Biochem; 2021 Oct; 122(10):1556-1566. PubMed ID: 34254709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microRNA-429/DUSP4 axis regulates the sensitivity of colorectal cancer cells to nintedanib.
    Cheng G; Li Y; Liu Z; Song X
    Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33495832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
    Shi Y; Ma IT; Patel RH; Shang X; Chen Z; Zhao Y; Cheng J; Fan Y; Rojas Y; Barbieri E; Chen Z; Yu Y; Jin J; Kim ES; Shohet JM; Vasudevan SA; Yang J
    Cell Death Dis; 2015 Aug; 6(8):e1841. PubMed ID: 26247726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells.
    Waha A; Felsberg J; Hartmann W; von dem Knesebeck A; Mikeska T; Joos S; Wolter M; Koch A; Yan PS; Endl E; Wiestler OD; Reifenberger G; Pietsch T; Waha A
    Cancer Res; 2010 Feb; 70(4):1689-99. PubMed ID: 20124482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DUSP4 Inactivation Leads to Reduced Extracellular Signal‒Regulated Kinase Activity through Upregulation of DUSP6 in Melanoma Cells.
    Kamada H; Yasuhira S; Shibazaki M; Amano H; Maesawa C
    J Invest Dermatol; 2022 Sep; 142(9):2499-2507.e6. PubMed ID: 35189148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulation of DUSP activity in EGFR-mutant lung cancer cell lines contributes to sustained ERK1/2 signaling.
    Britson JS; Barton F; Balko JM; Black EP
    Biochem Biophys Res Commun; 2009 Dec; 390(3):849-54. PubMed ID: 19836351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4.
    Xu X; Gao F; Wang J; Tao L; Ye J; Ding L; Ji W; Chen X
    Cancer Biol Ther; 2018 May; 19(5):427-435. PubMed ID: 29509059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.